Postnatal development and adult function of the central nervous system are dependent on the capacity of neurons to effect long-term changes of specific properties in response to neural activity. This neuronal response has been demonstrated to be tightly correlated with the expression of a set of regulatory genes which include transcription factors as well as molecules that can directly modify cellular signaling. It is hypothesized that these proteins play a role in activitydependent responses. Previously, we described the expression and regulation in brain of an inducible form of prostaglandin synthase/cyclooxygenase, termed COX-2. COX-2 is a ratelimiting enzyme in prostanoid synthesis and its expression is rapidly regulated in developing and adult forebrain by physiological synaptic activity. Here we demonstrate that COX-2 immunoreactivity is selectively expressed in a subpopulation of excitatory neurons in neo-and allocortices, hippocampus, and amygdala and is compartmentalized to dendritic arborizations. Moreover, COX-2 immunoreactivity is present in dendritic spines, which are specialized structures involved in synaptic signaling. The developmental profile of COX-2 expression in dendrites follows well known histogenetic gradients and coincides with the critical period for activitydependent synaptic remodeling. These results suggest that COX-2, and its diffusible prostanoid products, may play a role in postsynaptic signaling of excitatory neurons in cortex and associated structures.
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Neural activity results in specific structural and functional modifications of the cerebral cortex. This activity-dependent process is essential for achieving the appropriate synaptic relationships during development and for normal function of the mature cortex (1) . Recent studies are beginning to identify molecular mechanisms underlying activity-dependent changes (2) . There is abundant correlative evidence linking neural activity and transcription factor (TF) expression (3) . Members of the Fos, Jun, and zinc finger TF families are naturally expressed at high levels in specific populations of cortical neurons and this expression is tightly regulated by synaptic activity (4, 5) . Furthermore, these TFs are also rapidly and transiently induced in different paradigms of synaptic plasticity consistent with the notion that they regulate the expression of specific effector genes that underlie long-term plasticity (3) .
In addition to TFs, the initial genomic response to neural activity includes proteins that can directly modify cellular function. Among them is an inducible form of the enzyme prostaglandin synthase/cyclooxygenase, termed COX-2 (6) (7) (8) (9) . Cyclooxygenase is the first enzyme in the prostaglandin/ prostacyclin/thromboxane pathway and converts arachidonic acid to prostaglandin G2/prostaglandin H2. There are presently two known forms of cyclooxygenase: a constitutively expressed form termed COX-1 (10) and the inducible form
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COX-2 (6-9). In peripheral tissues, the predominant form of prostaglandin synthase is COX-1, but in response to inflammatory stimuli the level of COX-2 rapidly increases and contributes to the inflammatory response (11, 12) . Brain also possesses cyclooxygenase activity (13) , but in distinction to peripheral tissues COX-2 is expressed at high levels in normal brain (9) . COX-2 appears to be expressed exclusively in neurons and not in glia or microglia (9, 14) , which play a role in inflammatory responses. Moreover, neuronal expression is dynamically regulated by physiological synaptic activity (9) . These observations suggest a role for COX-2 in activitydependent neuronal plasticity and provide an interesting contrast with the demonstrated role of COX-2 in inflammatory responses in peripheral tissues.
Recent studies indicate that COX-1 and COX-2 possess distinctive intracellular compartmentalizations, which may be indicative of differential functions for these enzymes (15) . In our initial studies of COX-2 expression and regulation in brain, we were not able to assess the precise intracellular distribution of COX-2 due to technical limitations of the available polyclonal antiserum (9) . Recently, Breder et al. (16) performed a more detailed analysis of COX-2 localization in rat brain by using a similarly generated polyclonal antiserum and confirmed our previous reports of prominent localization to cortex and hippocampus (9, 14) . While immunostaining in most neurons was associated with the cell body, they detected COX-2 in dendrites of a small subset of large neurons in allocortical regions. In the present study, we have developed high-affinity COX-2-specific monoclonal antibodies that afford excellent histochemical definition, and we demonstrate that COX-2 immunoreactivity (ir) is consistently localized to neuronal dendrites of excitatory neurons and is frequently visualized in dendritic spines. Because dendritic spines are specialized structures involved in synaptic signaling, this localization suggests a role for COX-2 in the synaptic physiology of specific populations of excitatory neurons. Aspects of this work have been reported previously in abstract form (14) .
MATERIALS AND METHODS
Monoclonal Antibody Generation and Characterization. Hybridomas were generated by standard methods against recombinant full-length mouse (m) COX-2 expressed by baculovirus (17) . The to nitrocellulose membranes, incubated with the high-affinity monoclonal antibodies, and developed using ECL (Amersham) as described (19) . Determination of antibody specificity was done by preabsorption of R6 (100 ,ug/ml) with either COX-1 (28 ,uM) or COX-2 (21 ,uM) prior to immunochemical studies.
Animal Preparation. Male Sprague-Dawley rats were sacrificed at postnatal days (P) 1, 5, 10, 15, and 21, and adulthood (3 months and older) by perfusion/fixation in 4% paraformaldehyde as described (19) . A second group of young adult rats was subjected to a single maximal electroconvulsive seizure (MECS) using a constant current electroconvulsive treatment (ECT) unit as reported (20) and processed for immunohistochemistry at different time points after MECS (1-24 hr).
Immunochemical Techniques. Immunoblotting assays of brain and peripheral tissue samples were performed as described above. Immunocytochemistry was done using coronal sections that were cut either on a sliding microtome at ,um (perfused samples) or on a cryostat at 20-25 ,um (freshfrozen tissue). For single labeling of COX-2, both fixed/free floating sections and slide-mounted fresh-frozen tissue were processed according to the avidin-biotin procedure after incubation with primary antibodies (21) . Chromogen enhancement by cobalt chloride and/or nickel chloride was used to stain fine cellular processes. Double-labeling of COX-2 with other neural markers was carried out by sequential immunofluorescence assays on free-floating sections as reported (22) . The following markers were used: astrocytes, glial fibrillary acidic protein; excitatory/pyramidal neurons, glutamate (23), a subunit of calmodulin-dependent protein kinase II (CaMKII) (24), SMI-32, an antibody that labels nonphosphorylated neurofilaments (25) , and microtubule-associated protein 2 (MAP-2) (26); and GABAergic neurons, calbindin-D28k (CaBP), and parvalbumin (PV) (27) .
RESULTS
Antibody Specificity. Immunoblotting analyses of samples from several brain regions and visceral organs showed a consistent pattern with the three antibodies. A double band at '70 kDa is apparent in brain and peripheral tissues (Fig. 1A ), in agreement with previous studies (15, 28) . In addition, a single band at -43 kDa was also observed, predominantly in brain (Fig. 1A) . Preabsorption of the antibody with recombinant COX-2 markedly reduced staining for all three bands in brain samples (Fig. 1A) COX-2, but not with COX-1, virtually abolished tissue staining (Fig. 1B) . Consequently, R6 antibody was used for all highresolution anatomical studies. Previously, we demonstrated that COX-2 mRNA and ir are rapidly induced in hippocampus following MECS (9) . Confirming the specificity of the antibody R6, immunostaining of COX-2 was markedly induced in hippocampus by MECS (Fig. 1C) .
COX-2 ir in the Forebrain. In general agreement with our earlier studies on COX-2 mRNA distribution (9), we found that COX-2-ir was differentially distributed in the adult rat brain and was circumscribed to forebrain structuresspecifically; neocortex, allocortices, amygdala, and hippocampus (14) (Fig. 2) . In neo-and allocortices, COX-2-ir was enriched in laminae II-Ill with the exception of dorsomedial areas where it was also present in layer V. Pyramidal neurons of cortical layers II/III surrounding the rhinal sulcus showed particularly high density and intensity of COX-2-ir. In the hippocampus, staining was circumscribed to dentate gyrus, hilus, CA3/4, and subiculum. In the amygdala, COX-2-ir was heterogeneously distributed with some preference for lateral nuclei. In these regions with prominent COX-2-ir, immunostained cells represented approximately one-fourth to one-half of the neuronal population. COX-2 Immunostaining Is Present in Distal Dendrites and Dendritic Spines. In all forebrain regions, COX-2-ir cells displayed neuronal features. COX-2-ir was invariably present in the perikaryon, particularly in its peripheral region. In addition, virtually all immunostained neurons showed some degree of staining of the proximal dendritic segments. COX-2-ir was also detected in distal dendrites of most of pyramidal cells in cortical layers II/III, granule cells neurons in the dentate gyrus, and spindle-shaped neurons in the lateral amygdaloid nucleus (Fig. 3) . In general, neurons with distal dendritic staining exhibited the most intense ir, suggesting that sensitivity may be a limiting factor in detecting this COX-2-ir in less strongly positive neurons. COX-2-ir was present in both apical and basal dendrites without a clear preferential localization to either domain. Fine analysis of dendritic labeling, carried out mainly with metal-enhanced preparations, revealed that the staining in dendrites was patchy, with localized foci of high-intensity staining (Fig. 4) . This patchiness was detected throughout the dendritic tree and was most obvious in those neurons with intense COX-2-ir. Superimposed on the elongated patches were rounded foci of COX-2-ir that were marginal to the dendritic branches. Higher-power evaluations revealed that these rounded patches corresponded to the distal portion of dendritic spines and included round-to ovoidshaped morphologies. Spine shafts were occasionally visualized. Neurons with COX-2-ir spines were detected in all brain regions with COX-2-positive neurons (Fig. 4) .
Developmental Profile of COX-2-ir. The COX-2-ir developmental profile paralleled that of COX-2 mRNA as reported (9) . COX-2-ir was first detected at P10 in the hippocampus, specifically in the subiculum, suprapyramidal blade of the dentate gyrus, and CA4. There was a progressive increase in immunostaining that reached the adult pattern in terms of density and intensity of COX-2-ir cells by P21 (Fig. 5A) . and deep-superficial developmental gradients (Fig. 5 C and  D) . The amygdala showed a similar developmental timing to the cortex. However, as in the hippocampus, progression of COX-2-ir was in proportion to intensity of labeling seen in the adult brain. Although by P21 virtually all forebrain regions displayed the general adult pattern in terms of neuronal density, dendritic staining was present only in the areas of earlier detection (Fig. SB) . This contrasted with the rich dendritic network visualized by other dendritic markers such as MAP-2 (not shown).
Neurochemical Identity of COX-2-ir Neurons. Single labeling of COX-2-ir demonstrated its compartmentalization to neurons with morphological features of excitatory type (e.g., granule cells of the dentate gyrus, neocortical pyramidal neurons). To confirm this observation, double labeling was carried out of COX-2 with three specific markers of excitatory neurons (SMI-32, glutamate, CaMKII) and two markers of GABAergic cells (CaBP, PV). In all studied regions, virtually all COX-2-stained cells showed immunostaining for at least one of the excitatory markers, as well as for MAP-2, but not for CaBP and PV. COX-2-ir neurons represented a variable fraction of the neurons labeled by any marker (e.g., one-half to two-thirds glutamate ir neurons), in relationship with the relative enrichment of COX-2-ir in that particular region.
Extensive COX-2/SMI-32 colabeling was detected in cortical layers III and V, particularly in the dorsomedial aspects.
COX-2/glutamate colocalization was widespread, consistent with the abundance of glutamate-ir cells in cortex (Fig. 6A and  B) . CaMKII-ir was intense throughout the cortex (23) , and extensive colabeling of COX-2 and CaMKII was seen in ventrolateral cortices (not shown). In the hippocampus, as in the cerebral cortex, COX-2/SMI-32 colocalization was restricted while COX-2/glutamate was generalized (Fig. 6 C and  D) . CaMKII-ir/COX-2-ir also colocalized extensively in the pyramidal layer. In the amygdala, only glutamate ir was prominent and colocalized with COX-2-ir ( Fig. 6 E and F) . 
DISCUSSION
The major finding of the present study is that COX-2-ir is present in discrete foci of dendritic branches and in dendritic spines of excitatory pyramidal neurons in cerebral cortex and other telencephalic structures. COX-2-ir dendritic localization is developmentally regulated, following the main histogenetic gradients, with a pattern of expression that coincides with the critical period for activity-dependent cortical development (29) . Previously, we demonstrated that COX-2 expression is dynamically regulated by specific forms of synaptic activity that are associated with long-term neural plasticity (9) . This dynamic regulation by synaptic activity is shared by an expanding repertoire of immediate-early genes (IEGs) which exhibit diverse cellular functions (see below). The present data localize COX-2 to specialized structures involved in synaptic signaling.
Arachidonic acid is generated in response to N-methyl-Daspartate (NMDA) receptor activation in the striatum (30) and in the hippocampus in response to synaptic stimuli that induce long-term potentiation (LTP) (31) . We note that the product of COX-2 enzymatic activity, prostaglandin H2, could diffuse to distal sites of the same neuron or to contiguous cells where it would serve as substrate for synthesis of prostaglandins, prostacyclins, or thromboxane (13) . It is also notable that COX-2 activity is heme dependent and can be modulated by nitric oxide (32, 33) , a molecule that is widely studied as a retrograde signal in neuronal plasticity. Recent studies indicate that dendritic spines are not simply passive receptive sites but may play an active role in shaping neuronal activity and gene expression (34, 35) . In view of the many regulatory signals involved in COX-2 activity and its localization in spines, we hypothesize that COX-2 may generate a diffusible signal as a function of the activity at specific synapses. In support of this hypothesis, McNamara's group recently reported that c-fos is rapidly induced by NMDA or kainate receptor activation of cultured hippocampal neurons and that the NMDA-, but not the kainate-dependent response is selectively blocked by the COX inhibitor indomethacin (36) . Since the c-fos response must involve events at the cell nucleus, it suggests a COXdependent signal linking receptor activation and gene expression. In our studies to assess a possible role for COX-2 in LTP, we were unable to detect effects of indomethacin on either the initial induction or duration of LTP (9). Nevertheless, it is possible that induced prostanoids modify functions other than synaptic efficacy. Prostanoid synthases are enriched not only in brain neurons but also in glia and vascular endothelial cells (13) , and prostanoids exert a wide range of effects in different tissues including modification of cellular structure (37) . The recent development of a new series of potent and selective COX-1 and COX-2 inhibitors (11, 12, 38) will be useful to assess the physiological function of prostanoids in brain.
COX-2 is widely expressed in peripheral tissues. In both endothelial cells and 3T3 fibroblasts, COX-2-ir and enzymatic activity are enriched in the endoplasmic reticulum and nuclear envelope (15) . By contrast, COX-2-ir is enriched in dendrites and dendritic spines of brain neurons. These characteristic localizations indicate that COX-2 is selectively targeted to subcellular compartments, in a tissue-specific manner, and suggest tissue-specific roles for cyclooxygenase in cellular signaling.
COX-2 is representative of an emerging class of IEGs that can directly modify cellular function (19, (39) (40) (41) . In general terms, these IEGs are similar to TFs in that they interact with constitutively expressed networks of functionally related proteins and modify the function of the larger network. Just as TFs interact with the basal transcriptional apparatus, COX-2 acts with the complex set of enzymes involved in prostanoid synthesis and is the nodal enzyme in this synthetic pathway. Since COX-2 expression is tightly regulated by neuronal activity, we infer that neurons regulate the production of prostaglandins by controlling the availability of COX-2. Cyclooxygenase is an important pharmacological target and based on this precedent, as well as the regulatory function of other IEGs, we suggest that IEGs may identify nodal or regulatory points of important biochemical pathways for pharmaceutical development.
